Alkem Share Price
(ALKEM)
₹4720
as on 04:01PM, 20 Feb 2025
Alkem Performance
Day's Low
Day's High
₹4,690.5Day's Price Range₹4,768.652 Week's Low
52 Week's High
₹4,407.0552-Week Price Range₹6,439.9
| Returns % | |
| 1 Month Return | -9.47 % |
| 3 Month Return | -15.4 % |
| 1 Year Return | -12.24 % |
| Market Stats | |
| Previous Close | ₹4,741.70 |
| Open | ₹4,712.00 |
| Volume | 2.01L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹56,694.14Cr |
Alkem Key Statistics
P/E Ratio
26.33
PEG Ratio
0.54
Market Cap
₹56,694.14 Cr
P/B Ratio
5.6
EPS
151.52
Dividend Yield
0.81
Sector
Pharmaceuticals
ROE
17.56
Alkem Mutual Fund Holdings
Alkem Analyst Rating
based on 21 analysts
38.10%
Buy
28.57%
Hold
33.33%
Sell
Based on 21 analysts offering long term price targets for Alkem. An average target of ₹5395.95
Source: S&P Global Market Intelligence
Alkem Share analysis
Alkem price forecast by 21 analysts
Upside of13.80%
High
₹6642
Target
₹5395.95
Low
₹4186
Alkem target price ₹5395.95, a slight upside of 13.8% compared to current price of ₹4720. According to 21 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Alkem revenue growth forecast
Expected growth rate Q1, FY2027:24.18%
Forecast
Actual
Including amortisation and stock based compensations
Alkem EPS growth forecast
EPS estimate Q1, FY2027:46.81%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Alkem Laboratories Ltd
Alkem Laboratories Declares Dividend Amid Profit Rise - 14 Feb, 2025
Alkem Laboratories announced an interim dividend of Rs 37 per share for FY 2024-25. The company reported a 5.2% YoY profit increase in Q3FY25, but shares fell 2.23% due to the ex-dividend date.Alkem Laboratories Faces Decline Amid Acquisitions - 10 Feb, 2025
Alkem Laboratories reported a 5% YoY profit increase but faced a 6.5% stock drop due to declining domestic business and acquisitions. Trading volume surged significantly despite the decline.Alkem Laboratories Reports Growth and Strategic Acquisitions - 07 Feb, 2025
Alkem Laboratories reported a 5% rise in Q3 net profit and announced a ₹37 interim dividend. The company is acquiring Adroit Biomed and Bombay Ortho to enhance its market position in dermatology and medical devices.Alkem Laboratories Launches Kojiglo Serum, Shares Rise - 05 Feb, 2025
Alkem Laboratories launched Kojiglo Serum, a pioneering liposomal product for facial hyperpigmentation, leading to a 1.7% increase in share price. The company is set for a board meeting to discuss financial results and interim dividends.Alkem Launches Innovative Kojiglo Serum in India - 04 Feb, 2025
Alkem Laboratories has introduced Kojiglo serum, the first in India featuring Duo-Lipo technology, aimed at treating facial hyperpigmentation. This product enhances skin absorption and efficacy, expanding Alkem's skincare portfolio and reinforcing its market position.
Insights on Alkem Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, ALKEM stock has moved up by 0.5%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 9.02% to 10.15% in Dec 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 16.10% to 16.18% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 92.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.66% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 72.1%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 14.94% to 14.01% in Dec 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 688.64 Cr → 625.82 Cr (in ₹), with an average decrease of 9.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 3.54K Cr → 3.46K Cr (in ₹), with an average decrease of 2.3% per quarter
Alkem Financials
Index Inclusions
Alkem Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.66% | 0.00 | |
| Foreign Institutions | 10.15% | 12.45 | |
| Mutual Funds | 14.01% | ||
| Retail Investors | 16.18% | 0.47 | |
| Others | 4% |
Alkem Key Indicators
Alkem Valuation
Alkem in the last 5 years
Lowest (20.07x)
March 24, 2021
Today (26.33x)
February 19, 2025
Industry (51.87x)
February 19, 2025
Highest (44.21x)
August 9, 2023
Alkem Earnings and Dividends
Alkem Laboratories Ltd Earnings Results
Alkem Laboratories Ltd’s net profit jumped 5.19% since last year same period to ₹625.82Cr in the Q3 2024-2025. On a quarterly growth basis, Alkem Laboratories Ltd has generated -9.12% fall in its net profits since last 3-months.
Read More about Earnings ResultsAlkem Laboratories Ltd Dividends February,2025
In the quarter ending December 2024, Alkem Laboratories Ltd has declared dividend of ₹37 - translating a dividend yield of 1.62%.
Read More about Dividends
Alkem Technicals Summary
Bearish
Neutral
Bullish
Alkem Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Alkem Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹56,694.14 Cr | 15.67% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| HOLD | ₹21,840.22 Cr | 12.28% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹29,483.63 Cr | 104.16% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| BUY | ₹9,521.57 Cr | 9.92% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹3,805.61 Cr | 3.46% | 0.54 | ₹69 Cr | ₹571 Cr |
About Alkem
With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.
Share Price: ₹4720.00 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹56,694.14Cr as of today
Revenue: ₹3,374.28Cr as on December 2024 (Q4 24)
Net Profit: ₹640.79Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
| Organisation | Alkem |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Alkem Laboratories Ltd
What is Alkem Laboratories Ltd price today?
Alkem Laboratories Ltd share price today stands at ₹4720, Open: ₹4712, Previous Close: ₹4741.7, High: ₹4768.6, Low: ₹4690.5, 52 Week High: ₹6439.9, 52 Week Low: ₹4407.05.
How to Buy Alkem Laboratories Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Alkem Laboratories Ltd shares
Is Alkem Laboratories Ltd listed on NSE?
Alkem Laboratories Ltd is listed on NSE
Is Alkem Laboratories Ltd listed on BSE?
Alkem Laboratories Ltd is listed on BSE
What are today's High and Low prices of Alkem Laboratories Ltd?
- Today's highest price of Alkem Laboratories Ltd is ₹4768.6.
- Today's lowest price of Alkem Laboratories Ltd is ₹4690.5.
What are today's traded volumes of Alkem Laboratories Ltd?
Today's traded volume of Alkem Laboratories Ltd(ALKEM) is 2.01L.
What is today's market capitalisation of Alkem Laboratories Ltd?
Today's market capitalisation of Alkem Laboratories Ltd(ALKEM) is ₹56694.14Cr.
What is the 52 Week High and Low Range of Alkem Laboratories Ltd?
How much percentage Alkem Laboratories Ltd is down from its 52 Week High?
Alkem Laboratories Ltd (ALKEM) share price is ₹4720. It is down -26.71% from its 52 Week High price of ₹6439.9
How much percentage Alkem Laboratories Ltd is up from its 52 Week low?
Alkem Laboratories Ltd (ALKEM) share price is ₹4720. It is up 7.10% from its 52 Week Low price of ₹4407.05
What are the historical returns of Alkem Laboratories Ltd?
What is the PE ratio of Alkem Laboratories Ltd today?
PE Ratio of Alkem Laboratories Ltd is 26.33
PE ratio = Alkem Laboratories Ltd Market price per share / Alkem Laboratories Ltd Earnings per share